Author:
Mischoulon David,Best-Popescu Catherine,Laposata Michael,Merens Wendelien,Murakami Jessica L.,Wu Shirley L.,Papakostas George I.,Dording Christina M.,Sonawalla Shamsah B.,Nierenberg Andrew A.,Alpert Jonathan E.,Fava Maurizio
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology
Reference29 articles.
1. Arachidonic acid to eicosapentaenoic acid ration in blood correlates positively with clinical symptoms of depression;Adams;Lipids,1996
2. The changing rate of major depression: cross national comparisons;Cross-National Collaborative Group;JAMA,1992
3. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W. (1995) Structured Clinical Interview for Axis I DSM-IV Disorders — Patient Edition (With Psychotic Screen) (SCID-I/P (w/ psychotic screen)) (Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, 722 West 168th Street, New York, NY 10032.
4. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study;Frangou;Br. J. Psychiatry,2006
5. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression;Freeman;Acta Psychiatr. Scand.,2006
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献